ETC
EW icon

Exchange Traded Concepts’s Edwards Lifesciences EW Stock Holding History

Exchange Traded Concepts’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
12,022
+53
+0.4% +$4.44K 0.01% 903
2026
Q1 		$958K Sell
11,969
-6,552
-35% -$540K 0.01% 830
2025
Q4 		$1.58M Sell
18,521
-2,383
-11% -$196K 0.01% 651
2025
Q3 		$1.63M Buy
20,904
+626
+3% +$48.9K 0.01% 622
2025
Q2 		$1.59M Sell
20,278
-817
-4% -$60.9K 0.02% 539
2025
Q1 		$1.53M Buy
21,095
+8,453
+67% +$605K 0.03% 444
2024
Q4 		$936K Sell
12,642
-1,062
-8% -$74.3K 0.02% 591
2024
Q3 		$904K Sell
13,704
-2,797
-17% -$203K 0.02% 554
2024
Q2 		$1.52M Sell
16,501
-992
-6% -$87.8K 0.04% 365
2024
Q1 		$1.67M Sell
17,493
-4,564
-21% -$383K 0.04% 316
2023
Q4 		$1.68M Sell
22,057
-1,218
-5% -$84.7K 0.04% 302
2023
Q3 		$1.61M Sell
23,275
-32,478
-58% -$2.61M 0.05% 276
2023
Q2 		$5.26M Buy
55,753
+30,320
+119% +$2.64M 0.13% 158
2023
Q1 		$2.1M Buy
25,433
+870
+4% +$68.4K 0.06% 192
2022
Q4 		$1.83M Buy
24,563
+2,286
+10% +$176K 0.05% 193
2022
Q3 		$1.84M Buy
22,277
+2,040
+10% +$196K 0.06% 158
2022
Q2 		$1.92M Sell
20,237
-4,551
-18% -$471K 0.06% 166
2022
Q1 		$2.92M Sell
24,788
-4,346
-15% -$488K 0.06% 179
2021
Q4 		$3.77M Sell
29,134
-4,979
-15% -$581K 0.07% 160
2021
Q3 		$3.86M Buy
34,113
+1,369
+4% +$156K 0.1% 133
2021
Q2 		$3.39M Buy
32,744
+5,274
+19% +$497K 0.11% 149
2021
Q1 		$2.3M Buy
27,470
+9,119
+50% +$771K 0.09% 189
2020
Q4 		$1.67M Buy
18,351
+10,149
+124% +$842K 0.08% 171
2020
Q3 		$655K Buy
8,202
+3,263
+66% +$255K 0.04% 238
2020
Q2 		$341K Sell
4,939
-4,628
-48% -$329K 0.06% 283
2020
Q1 		$602K Buy
9,567
+954
+11% +$68.8K 0.33% 82
2019
Q4 		$670K Buy
+8,613
New +$673K 0.14% 79

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Exchange Traded Concepts's EW Position: Q2 2026 in Review

Exchange Traded Concepts increased its Edwards Lifesciences (EW) stake by 0.44% in Q2 2026, buying an estimated $4.44K and bringing the position to 12,022 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #903.

Exchange Traded Concepts first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.26M in Q2 2023. 296 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Exchange Traded Concepts held 12,022 shares of Edwards Lifesciences worth $1.09M as of Q2 2026.
  • Exchange Traded Concepts bought 53 Edwards Lifesciences shares in Q2 2026, an estimated $4.44K.
  • Edwards Lifesciences made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #903 holding.
  • Exchange Traded Concepts first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Edwards Lifesciences position peaked at $5.26M in Q2 2023.
  • 296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.